Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's clinical trials network

American Journal of Psychiatry

Volumn 167, Issue 1, 2010, Pages 95-101

  Hien, Denise A ^a   Jiang, Huiping ^a   Campbell, Aimee N C ^a   Hu, Mei Chen ^a   Miele, Gloria M ^a   Cohen, Lisa R ^a   Brigham, Gregory S ^a   Capstick, Carrie ^a   Kulaga, Agatha ^a   Robinson, James ^a   Suarez Morales, Lourdes ^a   Nunes, Edward V ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; GROUP THERAPY; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALCOHOLISM; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE CHANGE EVENTS; LONGITUDINAL STUDIES; MARKOV CHAINS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); PATIENT EDUCATION AS TOPIC; PSYCHOTHERAPY, GROUP; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 73949122652     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09091261     Document Type: Article

References (22)

1. Chilcoat HD, Menard C: Epidemiological investigations: comorbidity of posttraumatic stress disorder and substance use disorder, in Trauma and Substance Abuse: Causes, Consequences and Treatment of Comorbid Disorders. Edited by Ouimette PC, Brown PJ. Washington, DC, American Psychological Association, 2003, pp 9-28
2. Khantzian EJ: Treating Addiction as a Human Process. London, Jason Aronson, 1999
3. Khantzian EJ: The ego, the self, and opiate addiction: theoretical and treatment considerations. Int J Psychoanal 1977; 5:189-199
4. Chilcoat HD, Breslau N: Investigations of causal pathways between PTSD and drug use disorders. Addict Behav 1998; 23:827-840
5. Dixon L, Haas G, Weiden PJ: Drug abuse in schizophrenia patients: clinical correlates and reasons for use. Am J Psychiatry 1991; 148:224-230
6. Noordsy DL, Drake RE, Teague GB: Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 1991; 179:410-414
7. Addington J, Duckak V: Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96:329-333
8. Goswami S, Mattoo SK, Basu D, Singh G: Substance-abusing schizophrenics: do they self-medicate? Am J Addict 2004; 13:139-150
9. Back SE, Brady KT, Sonne SC , Verduin M: Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis 2006; 194:690-696
10. Najavits LM: Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. New York, Guilford, 2002
11. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM: The development of a clinician-administered PTSD scale. J Trauma Stress 1995; 8:75-90
12. Foa E, Riggs DS, Dancu CV, Constance V, Rothbaum BO: Reliability and validity of a brief instrument for assessing posttraumatic stress disorder. J Trauma Stress 1993; 6:459-473
13. McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP: A new measure of substance abuse treatment: initial studies of the treatment services review. J Nerv Ment Dis 1992; 180:101-110
14. McLellan AT, Luborsky L, Cacciola J: New data from the addiction severity index: reliability and validity in three centers. J Nerv Ment Dis 1985; 173:412-423
15. McGahan PL, Griffith JA, Parente R, McLellan, AT: Addiction Severity Index: composite scores manual. Philadelphia, The University of Pennsylvania, Veterans Administration Centre for Studies of Addiction, 1986
16. Sobell LC , Sobell MB: Timeline Followback: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biological Methods. Edited by Litten RZ, Allen JT. Towota, NJ, Humana Press, 1992, pp 41-72
17. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM: Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000; 283:1837-1844
18. Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, Woody G: Imipramine treatment of opiate-dependent patients with depressive disorders: a placebo-controlled trial. Arch Gen Psychiatry 1998; 55:153-160
19. Marshall G, Jones, RH: Multi-state models and diabetic retinopathy. Stat Med 1995; 14:1975-1983
20. Diggle PJ, Liang KY, Zeger SL: Analysis of Longitudinal Data. Oxford, UK, O xford University Press, 2004
21. Hien DA, Cohen LR, Miele GM, Litt LC , Capstick C: Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry 2004; 161:1426-1432
22. Klein DF, Ross DC: Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program general effectiveness report. Neuropsychopharmocology 1993; 8:241-251